Stem cell treatments for amyotrophic lateral sclerosis: A critical overview of early phase trials (vol 28, pg 525, 2019)

被引：0
|
作者：
Goutman, S. A.
Savelieff, M. G.
Sakowski, S. A.
机构：
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2019年 / 29卷 / 07期
关键词：
D O I：
10.1080/13543776.2019.1639316
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：579 / 585
页数：7
相关论文
共 50 条
  • [31] The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis (vol 16, pg 1149, 2019)
    Bose, Poulomee
    Tremblay, Elsa
    Maios, Claudia
    Narasimhan, Vijay
    Armstrong, Gary A. B.
    Liao, Meijiang
    Parker, J. Alex
    Robitaille, Richard
    Wen, Xiao Yan
    Barden, Christopher
    Drapeau, Pierre
    NEUROTHERAPEUTICS, 2021, 18 (03) : 2128 - 2128
  • [32] Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment? (vol 11, pg 1216, 2016)
    Santiago, Marcelo F.
    NEURAL REGENERATION RESEARCH, 2016, 11 (09) : 1449 - 1449
  • [33] Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis (vol 5, 16953, 2015)
    Fontanilla, Christine V.
    Gu, Huiying
    Liu, Qingpeng
    Zhu, Timothy Z.
    Zhou, Changwei
    Johnstone, Brian H.
    March, Keith L.
    Pascuzzi, Robert M.
    Farlow, Martin R.
    Du, Yansheng
    SCIENTIFIC REPORTS, 2016, 6
  • [34] The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type (vol 28, pg 47, 2019)
    Pejovic, T.
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 35
  • [35] Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis Results of Phase 1/2 and 2a Clinical Trials
    Petrou, Panayiota
    Gothelf, Yael
    Argov, Zohar
    Gotkine, Marc
    Levy, Yossef S.
    Kassis, Ibrahim
    Vaknin-Dembinsky, Adi
    Ben-Hur, Tamir
    Offen, Daniel
    Abramsky, Oded
    Melamed, Eldad
    Karussis, Dimitrios
    JAMA NEUROLOGY, 2016, 73 (03) : 337 - 344
  • [36] Generation of an induced pluripotent stem cell line (UCSCi001-A) from a patient with early-onset amyotrophic lateral sclerosis carrying a FUS variant
    Martello, Francesco
    Lattante, Serena
    Doronzio, Paolo Niccolo
    Conte, Amelia
    Bisogni, Giulia
    Orteschi, Daniela
    Pirozzi, Filomena
    Sabatelli, Mario
    Zollino, Marcella
    Marangi, Giuseppe
    STEM CELL RESEARCH, 2021, 55
  • [37] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial (vol 12, pg 339, 2013)
    Allen, C.
    LANCET NEUROLOGY, 2013, 12 (09): : 846 - 846
  • [38] Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation P525L (c.1574C > T) in FUS gene
    Akter, Masuma
    Cui, Haochen
    Hosain, Md Abir
    Ding, Baojin
    STEM CELL RESEARCH, 2023, 69
  • [39] Mitochondrial Modulation by Dichloroacetate Reduces Toxicity of Aberrant Glial Cells and Gliosis in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis (vol 16, pg 203, 2019)
    Martinez-Palma, Laura
    Miquel, Ernesto
    Lagos-Rodriguez, Valentina
    Barbeito, Luis
    Cassina, Adriana
    Cassina, Patricia
    NEUROTHERAPEUTICS, 2020, 17 (04) : 2089 - 2089
  • [40] Positive effect of transplantation of hNT Neurons (NTera 2/D1 cell-line) in model of familial amyotrophic lateral sclerosis (vol 174, pg 169, 2002)
    Garbuzova-Davis, S
    Willing, AE
    Milliken, M
    Saporta, S
    Zigova, T
    Cahill, DW
    Sanberg, PR
    EXPERIMENTAL NEUROLOGY, 2002, 175 (02) : 451 - 451
12345